揭开分子景观:神经母细胞瘤中的长非编码RNA (评论)
Zidong Xia1, Huishan Zhai1, Lei Zheng1
1Department of Pediatric Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.
Oncology reports
|March 13, 2026
概括
长非编码RNAs (lncRNAs) 是神经母细胞瘤 (NB) 发展和进展的关键驱动因素. 了解lncRNA机制为这种儿科癌症提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 神经母细胞瘤 (NB) 是儿童癌症死亡的主要原因,目前的治疗方法面临局限性.
- 尽管免疫疗法和向疗法取得了进展,但超过三分之一的高风险NB患者表现出耐药性或不反应.
- 失调的长非编码RNA (lncRNA) 表达越来越多地与NB预后,诊断和治疗结果有关.
研究的目的:
- 系统地审查 lncRNAs 在神经母细胞瘤发育和进展中的分子机制.
- 为NB提供 lncRNAs作为新兴临床点的最新概述.
- 突出 lncRNAs 在开发 NB 新型诊断和治疗策略方面的潜力.
主要方法:
- 对调查神经母细胞瘤中lncRNA功能的研究进行系统性文献综述.
- 对 lncRNA 参与 NB 病变的分子机制的分析.
- 评估 lncRNAs 在NB管理中的当前和潜在的临床应用.
主要成果:
- 在神经母细胞瘤发育和进展的各个阶段,lncRNAs起着重要的作用.
- 特定的lncRNA与NB诊断,预后和对治疗的反应有关.
- 对lncRNA表达的失调是神经母细胞瘤的一个常见特征.
结论:
- lncRNAs是神经母细胞瘤中关键的分子参与者.
- lncRNAs作为NB早期诊断和预后的生物标志物具有前途.
- 针对 lncRNAs 可能导致神经母细胞瘤的新型精确治疗策略.
相关概念视频
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Non-LTR Retrotransposons
13.8K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.8K

